Get started
Author

Sharon Evans

A Randomized Clinical Trial of High-Dosage Coenzyme Q10 in Early Parkinson Disease
2014 · The Parkinson Study Group QE3 Investigators, M. Flint Beal, et al. · JAMA Neurology · 410
PDF
Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease
2016 · Huntington Study Group, Samuel Frank, et al. · JAMA · 403
PDF
Motor, cognitive, and functional declines contribute to a single progressive factor in early HD
2017 · Scott A. Schobel, Giuseppe Palermo, et al. · Neurology · 155
PDF
Efficacy of Nilotinib in Patients With Moderately Advanced Parkinson Disease
2020 · Tanya Simuni, Brian Fiske, et al. · JAMA Neurology · 148
PDF
A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease
2016 · Andrew McGarry, Michael McDermott, et al. · Neurology · 139
PDF
Long-Term Comparative Experience with Tolcapone and Entacapone in Advanced Parkinson's Disease
2001 · Stewart A. Factor, Eric S. Molho, et al. · Clinical Neuropharmacology · 61
Efficacy and safety of repeated doses of botulinum toxin type B in type A resistant and responsive cervical dystonia
2005 · Stewart A. Factor, Eric S. Molho, et al. · Movement Disorders · 53
Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease A Randomized Clinical Trial
2016 · Samuel Frank, Claudia Testa, et al. · Publisher · 45
Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS)
2015 · The Huntington Study Group PHAROS Investigators, Kevin Michael Biglan, et al. · JAMA Neurology · 45
PDF
The Safety of Deutetrabenazine for Chorea in Huntington Disease: An Open-Label Extension Study
2022 · Samuel Frank, Claudia Testa, et al. · CNS Drugs · 33
PDF
Activity enhances dopaminergic long-duration response in Parkinson disease
2012 · Un Jung Kang, Peggy Auinger, et al. · Neurology · 28
PDF
Works count: 11
Citation count: 1,519
H-index: 11
I10-index: 11
Year
Topic
Type